EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An antisense peptide-conjugated peptide nucleic acid (PPNA) for peptidoglycan recycling inhibition reduces AmpC hyperproduction and β–lactam resistance in Pseudomonas aeruginosa

Maria Escobar-Salom, Isabel M Barceló, Jordi Sansó-Sastre, Gabriel Torrens, Elena Jordana-Lluch iD, Bartolomé Moyà, Antonio Oliver iD, Carlos Juan iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.02622-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Maria Escobar-Salom und 7 weiteren Autor:innen. Beteiligte Einrichtung: ARPBIG group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Peptidoglycan, Bacterial Proteins, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Govern de les Illes Balears, Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We performed a proof-of-concept study to validate a peptide-conjugated peptide nucleic acid (PPNA) directed to inhibit peptidoglycan recycling as strategy to reduce AmpC hyperproduction and β-lactam resistance in Pseudomonas aeruginosa . Our nagZ -targeting PPNA at 2 µM decreased mRNA levels of nagZ and ampC to about a quarter in the AmpC high-level hyperproducer mutant PAdacBΔD and a previously characterized clinical strain with similar features, causing low cytotoxicity on human A549 cells. Ceftazidime minimum inhibitory concentration decreased from 64 to 8 mg/L in both strains after combination with 2 µM PPNA (which showed significant synergy in checkerboard assays), suggesting that nagZ -targeting PPNAs can be explored as weapons to sensitize P. aeruginosa against β-lactams and return therapeutic value to these essential drugs. IMPORTANCE In the current scenario of threatening antibiotic resistance rates in Pseudomonas aeruginosa , the quest for alternative therapeutic weapons must consider all options, including the use of antisense oligonucleotides (e.g., peptide-conjugated peptide nucleic acids [PPNAs]) to silence the production of key target proteins. In this regard, we designed a proof-of-concept study to validate a PPNA directed to inhibit peptidoglycan recycling as a strategy to impair AmpC β-lactamase hyperproduction and derived resistance in P. aeruginosa . Our results indicate that the designed PPNA (targeting the N-acetyl-glucosaminidase NagZ) at low concentrations significantly decreased AmpC production and ceftazidime resistance in clinically relevant high-level hyperproducer P. aeruginosa strains, suggesting interesting therapeutic potentials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaPeptidoglycanBacterial ProteinsAnti-Bacterial AgentsPeptide Nucleic Acidsbeta-Lactam Resistancebeta-LactamasesHumansMicrobial Sensitivity TestsCeftazidimebeta-LactamsA549 CellsPseudomonas Infections

Stichwörter der Autor:innen

AmpC β-lactamaseNagZPseudomonas aeruginosaceftazidimepeptide-conjugated peptide nucleic acid (PPNA)peptidoglycan recycling

Substanzen

PeptidoglycanBacterial ProteinsAnti-Bacterial AgentsAmpC beta-lactamasesPeptide Nucleic Acidsbeta-LactamasesCeftazidimebeta-Lactams

Autor:innen und Institutionen

  • ARPBIG group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
  • Microbiology Department, University Hospital Son Espases (HUSE), Palma, Spain.
  • Centro de Investigación Biomédica en Red, Área Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Department of Molecular Biology and Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå Centre for Microbial Research (UCMR), Umeå University, Umeå, Sweden.

ORCID-Profile: Elena Jordana-Lluch, Antonio Oliver, Carlos Juan

Förderung

  • Govern de les Illes Balears
  • Ministerio de Ciencia, Innovación y Universidades
  • Instituto de Salud Carlos III

Zitieren

APA

Escobar-Salom, M., Barceló, I. M., Sansó-Sastre, J., Torrens, G., Jordana-Lluch, E., Moyà, B., Oliver, A., & Juan, C. (2025). An antisense peptide-conjugated peptide nucleic acid (PPNA) for peptidoglycan recycling inhibition reduces AmpC hyperproduction and β–lactam resistance in Pseudomonas aeruginosa. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02622-24

Vancouver

Escobar-Salom M, Barceló IM, Sansó-Sastre J, Torrens G, Jordana-Lluch E, Moyà B, et al. An antisense peptide-conjugated peptide nucleic acid (PPNA) for peptidoglycan recycling inhibition reduces AmpC hyperproduction and β–lactam resistance in Pseudomonas aeruginosa. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02622-24

BibTeX
@article{EscobarSalom2025,
  author = {Escobar-Salom, Maria and Barceló, Isabel M and Sansó-Sastre, Jordi and Torrens, Gabriel and Jordana-Lluch, Elena and Moyà, Bartolomé and Oliver, Antonio and Juan, Carlos},
  title = {An antisense peptide-conjugated peptide nucleic acid (PPNA) for peptidoglycan recycling inhibition reduces AmpC hyperproduction and β–lactam resistance in Pseudomonas aeruginosa},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.02622-24}
}
Kostenlos starten →